571 related articles for article (PubMed ID: 22525471)
121. Management of hepatocellular carcinoma patients with portal vein tumor thrombosis: A narrative review.
Tao ZW; Cheng BQ; Zhou T; Gao YJ
Hepatobiliary Pancreat Dis Int; 2022 Apr; 21(2):134-144. PubMed ID: 34955380
[TBL] [Abstract][Full Text] [Related]
122. Efficacy of hepatic arterial infusion chemotherapy in combination with irradiation for advanced hepatocellular carcinoma with portal vein invasion.
Onishi H; Nouso K; Nakamura S; Katsui K; Wada N; Morimoto Y; Miyahara K; Takeuchi Y; Kuwaki K; Yasunaka T; Miyake Y; Shiraha H; Takaki A; Kobayashi Y; Sakaguchi K; Kanazawa S; Yamamoto K
Hepatol Int; 2015 Jan; 9(1):105-12. PubMed ID: 25788384
[TBL] [Abstract][Full Text] [Related]
123. Nonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization.
Kim JH; Yoon HK; Ko GY; Gwon DI; Jang CS; Song HY; Shin JH; Sung KB
Radiology; 2010 Apr; 255(1):270-7. PubMed ID: 20308463
[TBL] [Abstract][Full Text] [Related]
124. Effectiveness of stereotactic body radiotherapy for portal vein tumor thrombosis in patients with hepatocellular carcinoma and underlying chronic liver disease.
Choi HS; Kang KM; Jeong BK; Jeong H; Lee YH; Ha IB; Song JH
Asia Pac J Clin Oncol; 2021 Jun; 17(3):209-215. PubMed ID: 32757461
[TBL] [Abstract][Full Text] [Related]
125. New macroscopic classification and back-flow thrombectomy for advanced hepatocellular carcinoma with portal vein tumor thrombus invading the contralateral second portal branch.
Fukumoto T; Kido M; Takebe A; Tanaka M; Kinoshita H; Kuramitsu K; Komatsu S; Tsugawa D; Goto T; Asari S; Toyama H; Ajiki T; Ku Y
Surg Today; 2017 Sep; 47(9):1094-1103. PubMed ID: 28324163
[TBL] [Abstract][Full Text] [Related]
126. Treatment of hepatocellular carcinoma with portal venous tumor thrombosis: A comprehensive review.
Han K; Kim JH; Ko GY; Gwon DI; Sung KB
World J Gastroenterol; 2016 Jan; 22(1):407-16. PubMed ID: 26755886
[TBL] [Abstract][Full Text] [Related]
127. Downstaging with Localized Concurrent Chemoradiotherapy Can Identify Optimal Surgical Candidates in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
Chong JU; Choi GH; Han DH; Kim KS; Seong J; Han KH; Choi JS
Ann Surg Oncol; 2018 Oct; 25(11):3308-3315. PubMed ID: 30083834
[TBL] [Abstract][Full Text] [Related]
128. Conversion surgery for hepatocellular carcinoma with portal vein tumor thrombus after successful atezolizumab plus bevacizumab therapy: a case report.
Hidaka Y; Tomita M; Desaki R; Hamanoue M; Takao S; Kirishima M; Ohtsuka T
World J Surg Oncol; 2022 Jul; 20(1):228. PubMed ID: 35831894
[TBL] [Abstract][Full Text] [Related]
129. Clinical features and outcomes of patients with hepatocellular carcinoma complicated with bile duct invasion.
An J; Lee KS; Kim KM; Park DH; Lee SS; Lee D; Shim JH; Lim YS; Lee HC; Chung YH; Lee YS
Clin Mol Hepatol; 2017 Jun; 23(2):160-169. PubMed ID: 28506055
[TBL] [Abstract][Full Text] [Related]
130. The safety and efficacy of percutaneous ethanol injection in the treatment of tumor thrombus in advanced hepatocellular carcinoma with portal vein tumor thrombus.
Sun B; Zhang W; Chen L; Sun T; Ren Y; Zhu L; Qian K; Zheng C
Abdom Radiol (NY); 2022 Feb; 47(2):858-868. PubMed ID: 34820688
[TBL] [Abstract][Full Text] [Related]
131. Experience With LDLT in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis Postdownstaging.
Soin AS; Bhangui P; Kataria T; Baijal SS; Piplani T; Gautam D; Choudhary NS; Thiagarajan S; Rastogi A; Saraf N; Saigal S
Transplantation; 2020 Nov; 104(11):2334-2345. PubMed ID: 32032291
[TBL] [Abstract][Full Text] [Related]
132. Comparison of Liver Transplantation and Liver Resection for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus Type I and Type II.
Lv JY; Zhang NN; Du YW; Wu Y; Song TQ; Zhang YM; Qu Y; Liu YX; Gu J; Wang ZY; Qiu YB; Yang B; Tian DZ; Guo QJ; Zhang L; Sun JS; Xie Y; Wang ZL; Sun X; Jiang WT; Lu W
Yonsei Med J; 2021 Jan; 62(1):29-40. PubMed ID: 33381932
[TBL] [Abstract][Full Text] [Related]
133. Efficacy and safety of endovascular brachytherapy combined with transarterial chemoembolization for the treatment of hepatocellular carcinoma patients with type III or IV portal vein tumor thrombosis.
Li L; Cheng N; Huang X; Weng X; Jiao Y; Liu J; Guo W
World J Surg Oncol; 2022 Feb; 20(1):30. PubMed ID: 35109883
[TBL] [Abstract][Full Text] [Related]
134. Treatment of Naïve HCC Combined with Segmental or Subsegmental Portal Vein Tumor Thrombosis: Liver Resection
Yu JI; Choi GS; Lim DH; Lee E; Joh JW; Kwon CHD; Kim JM; Kim S; Woo SY; Paik SW; Park HC
Anticancer Res; 2018 Aug; 38(8):4919-4925. PubMed ID: 30061270
[TBL] [Abstract][Full Text] [Related]
135. Preoperative MRI-based multiparametric model for survival prediction in hepatocellular carcinoma patients with portal vein tumor thrombus following hepatectomy.
Zhang L; Zheng T; Wu Y; Wei H; Yang T; Zhu X; Yang J; Chen Y; Wang Y; Qu Y; Chen J; Zhang Y; Jiang H; Song B
Eur J Radiol; 2023 Aug; 165():110895. PubMed ID: 37276744
[TBL] [Abstract][Full Text] [Related]
136. Treatment of portal vein tumor thrombus of hepatocellular carcinoma with percutaneous laser ablation.
Lu ZH; Shen F; Yan ZL; Li J; Yang JH; Zong M; Shi LH; Wu MC
J Cancer Res Clin Oncol; 2009 Jun; 135(6):783-9. PubMed ID: 19034515
[TBL] [Abstract][Full Text] [Related]
137. Hepatic vein tumor thrombosis in patients with hepatocellular carcinoma: Prevalence and clinical significance.
Mähringer-Kunz A; Meyer FI; Hahn F; Müller L; Düber C; Pinto Dos Santos D; Galle PR; Weinmann A; Kloeckner R; Schotten S
United European Gastroenterol J; 2021 Jun; 9(5):590-597. PubMed ID: 34077613
[TBL] [Abstract][Full Text] [Related]
138. Safety and Efficacy of Irradiation Stent Placement for Malignant Portal Vein Thrombus Combined with Transarterial Chemoembolization for Hepatocellular Carcinoma: A Single-Center Experience.
Lu J; Guo JH; Zhu HD; Zhu GY; Chen L; Teng GJ
J Vasc Interv Radiol; 2017 Jun; 28(6):786-794.e3. PubMed ID: 28396192
[TBL] [Abstract][Full Text] [Related]
139. A new classification for hepatocellular carcinoma with portal vein tumor thrombus.
Shi J; Lai EC; Li N; Guo WX; Xue J; Lau WY; Wu MC; Cheng SQ
J Hepatobiliary Pancreat Sci; 2011 Jan; 18(1):74-80. PubMed ID: 20686792
[TBL] [Abstract][Full Text] [Related]
140. Prognostic value of the neutrophil-to-lymphocyte ratio for hepatocellular carcinoma patients with portal/hepatic vein tumor thrombosis.
Li SH; Wang QX; Yang ZY; Jiang W; Li C; Sun P; Wei W; Shi M; Guo RP
World J Gastroenterol; 2017 May; 23(17):3122-3132. PubMed ID: 28533669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
